0001209191-23-035613.txt : 20230608 0001209191-23-035613.hdr.sgml : 20230608 20230608211206 ACCESSION NUMBER: 0001209191-23-035613 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230606 FILED AS OF DATE: 20230608 DATE AS OF CHANGE: 20230608 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MIDDLETON FRED A CENTRAL INDEX KEY: 0001267959 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39538 FILM NUMBER: 231003643 MAIL ADDRESS: STREET 1: 400 SOUTH EL CAMINO REAL STE 1200 CITY: SAN MATEO STATE: CA ZIP: 94402-1708 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CalciMedica, Inc. CENTRAL INDEX KEY: 0001534133 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 452120079 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 505 COAST BOULEVARD SOUTH STREET 2: SUITE 307 CITY: LA JOLLA STATE: CA ZIP: 92037 BUSINESS PHONE: 858-952-5500 MAIL ADDRESS: STREET 1: 505 COAST BOULEVARD SOUTH STREET 2: SUITE 307 CITY: LA JOLLA STATE: CA ZIP: 92037 FORMER COMPANY: FORMER CONFORMED NAME: CalciMedica, Inc. /DE/ DATE OF NAME CHANGE: 20230322 FORMER COMPANY: FORMER CONFORMED NAME: GRAYBUG VISION, INC. DATE OF NAME CHANGE: 20170717 FORMER COMPANY: FORMER CONFORMED NAME: GRAYBUG, Inc. DATE OF NAME CHANGE: 20150303 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-06-06 0 0001534133 CalciMedica, Inc. CALC 0001267959 MIDDLETON FRED A C/O CALCIMEDICA, INC. 505 COAST S. BLVD. #202 LA JOLLA CA 92037 1 0 1 0 0 Common Stock 2023-06-06 4 P 0 500 4.8808 A 10500 D Common Stock 2023-06-07 4 P 0 500 5.20 A 11000 D Common Stock 703388 I By Sanderling Venture Partners VI, L.P. Common Stock 582757 I By Sanderling Venture Partners VI Co-Investment Fund, L.P. Common Stock 17682 I By Sanderling Ventures Management VI Common Stock 7456 I By Sanderling VI Beteligungs GmbH & Co KG Common Stock 8884 I By Sanderling VI Limited Partnership Common Stock 240676 I By Sanderling Ventures VII, L.P. Common Stock 14425 I By Sanderling Ventures VII Annex Fund, L.P. Common Stock 63228 I By Sanderling Ventures VII (Canada), L.P. Common Stock 1548 I By Sanderling Ventures Management VII Common Stock 8176 I By Golden Triangle Ventures, LLC The Reporting Person, a director of Sanderling Ventures, may be deemed to beneficially own the securities of the Issuer held by Sanderling Venture Partners VI, LP, Sanderling Venture Partners VI Co-Investment Fund, LP, Sanderling VI Beteiligungs GmbH & Co. KG, Sanderling Ventures Management VI and Sanderling VI Limited Partnership (together, the "Sanderling VI Securities"). The Reporting Person disclaims beneficial ownership of the Sanderling VI Securities except to the extent of his pecuniary interest therein. The Reporting Person, a director of Sanderling Ventures, may be deemed to beneficially own the securities of the Issuer held by Sanderling Ventures VII, LP, Sanderling Ventures Management VII, Sanderling Ventures VII (Canada), LP and Sanderling Ventures VII Annex Fund, L.P. (together, the "Sanderling VII Securities"). The Reporting Person disclaims beneficial ownership of the Sanderling VII Securities except to the extent of his pecuniary interest therein. The Reporting Person is a managing member of Golden Triangle Ventures LLC and may be deemed to beneficially own the securities of the Issuer held by Golden Triangle Ventures LLC. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. By John Dunn, Attorney-in-Fact 2023-06-08